New Zealand markets closed

MaaT Pharma SA (MAAT.PA)

Paris - Paris Delayed price. Currency in EUR
Add to watchlist
9.40+0.10 (+1.08%)
At close: 05:35PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
2,228
2,228
1,430
972
0
Cost of revenue
573
573
339
166
0
Gross profit
1,655
1,655
1,091
806
0
Operating expenses
Research development
21,006
21,006
14,476
9,252
6,099
Selling general and administrative
3,001
3,001
1,963
1,372
658
Total operating expenses
21,599
21,599
14,647
9,698
5,221
Operating income or loss
-19,944
-19,944
-13,556
-8,892
-5,221
Interest expense
402
402
185
121
45
Income before tax
-19,717
-19,717
-13,713
-9,019
-5,301
Income tax expense
-
-
0
0
0
Income from continuing operations
-19,717
-19,717
-13,713
-9,019
-5,301
Net income
-19,717
-19,717
-13,713
-9,019
-5,301
Net income available to common shareholders
-19,717
-19,717
-13,713
-9,019
-5,301
Basic EPS
-1.40
-
-1.40
-3.70
-5.10
Diluted EPS
-1.40
-
-1.40
-3.70
-5.10
Basic average shares
10,513
-
9,892
2,427
1,032
Diluted average shares
10,513
-
9,892
2,427
1,032